Small 1000 bp fragments of DNA derived from human malignant breast cancer cells have been isolated which, when transfected into a benign rat mammary cell line induce the production of osteopontin and thereby endow those cells with the capability to metastasize in syngeneic rats. Using transient transfections of an osteopontin promoter-reporter construct, we have now identi®ed the active moiety in the metastasis-inducing DNA as the binding site for the T cell factor (Tcf) family of transcription factors and located Tcf-4, b-catenin and E-cadherin in the relevant DNA complex in vitro. The regulatory eects of the metastasis-inducing DNAs are therefore exerted, at least in part, by a CAAAG sequence which can sequester Tcf-4, thereby promoting transcription of the direct eector for metastasis in this system, osteopontin. Oncogene (2001) 20, 1793 ± 1797.
Introduction
The majority of cancers, including breast cancer arise in benign proliferative lesions and then acquire multiple genetic changes, a few of which are responsible for causing dissemination and metastasis (Liotta et al., 1991) . To identify those genetic alterations which can promote metastasis in a dominant manner, we have transfected a stably diploid rat mammary epithelial cell line, Rat Mammary 37 (Rama 37), which makes benign, nonmetastasizing tumours in syngeneic rats (Dunnington et al., 1983) , with restriction enzymefragmented DNA from rat and human breast cell lines isolated from various sources. When they are injected subcutaneously in the mammary glands of syngeneic rats, the benign Rama 37 cells transfected with DNA from malignant metastatic cell lines produce transfectants that yield metastatic tumours; Rama 37 cells transfected with DNA from nonmalignant sources fail to do so (Davies et al., 1994) . The benign Rama 37 cells transfected with restriction enzyme-fragmented DNA from a human malignant breast cell line (Oates et al., 1996) yield transfectants which can produce at relatively high frequency metastatic tumours in syngeneic rats. Six metastasis-inducing DNAs (MetDNAs) have been isolated from such transfectants; they are *1000 bp in size and do not code for any expressed mRNAs (Chen et al., 1997b) . Transfection of all six Met-DNAs, one at a time, into the benign epithelial cells causes enhanced expression of osteopontin (OPN), whilst independent transfection of an expression vector for OPN also induces the metastatic state (Oates et al., 1996) . The most potent inducer of metastasis in the experimental rat model is C9-Met-DNA, and sequences contained within C9-Met-DNA are also detectable in some human breast cancers but not in normal tissue (Chen et al., 1997b) . Using transient transfections of an OPN promoter-reporter construct and gel shift assays with fragments of C9-Met-DNA, we have now identi®ed the active sequence contained within it. The regulatory eect of the C9-Met-DNA is probably exerted, in part, be sequestering a particular transcription factor, thereby promoting transcription of OPN, the direct eector for metastasis in this system.
To identify which region(s) of the most potent Met-DNA, C9-Met-DNA, are responsible for regulating the expression of the osteopontin gene, cloned Met-DNA fragments were transiently transfected into the benign Rama 37 cells together with a 2.3 kbp fragment of the OPN promoter (Ridall et al., 1995) coupled to a CAT reporter gene to measure OPN promoter activity. The full length C9-Met-DNA and its reverse sequence activated the OPN promoter in the same dosedependent manner (0.01 ± 1.0 ng per reaction) ( Figure  1 ), suggesting that it is unlikely to be expressed as mRNA. The pM9-DNA (96 bp), and its two halves pM10 and pM11-DNAs (48 bp) stimulated the OPN promoter at their optimum concentrations to 81, 56 and 53%, respectively, of that within C9-Met-DNA. The region of pM9 contained within pM10, pM12-DNA (20 bp) stimulated the OPN promoter by 59% of that of the full length Met-DNA, but pM12/D-DNA with the middle CAAAG sequence deleted was without eect (Figure 1 ). These results suggest that the Tcf transcription factor-binding site of CAAAG is the important region for stimulation of the OPN promoter. The consensus Tcf-binding sequence is M 1 AM 2 AG (M 1 ,M 2 = C or A) (van de Wetering et al., 1991) . Although there are seven other potential Tcf binding sites in C9-Met-DNA, none corresponded to CAAAG, and DNA fragments pM1 and pM5, containing only the other possible Tcf-binding sequences were inactive in this assay (Figure 1 ). In controls there was no stimulation of the promoter-CAT reporter construct for the metastasis-inducing protein S100A4 (p9Ka) (Chen et al., 1997a) by C9-Met-DNA, pM9-DNA or pM12-DNA (not shown).
Complex formation between fragments of C9-Met-DNA and cell or nuclear extracts of the Rama 37 cells was sought using gel retardation assays. The electrophoretic mobilities of [ P-labelled Met-DNA fragments with 10 mg nuclear protein extract (El-Tanani and Green, 1997), in 25 ml 0.05 M KC1, 1 mM MgC1 2 , 0.02 mM HEPES (pH 7.9), 0.5 mM dithiothreitol, 4% (w/v) Ficoll, 2 mg poly(dI,dC) (Pharmacia, Uppsala, Sweden), 0.01% (w/v) SDS for 40 min at 08C. Samples were electrophoresed through nondenaturing 4% (w/v) polyacrylamide gels, which were dried, exposed to Fuji X-Omat ®lm for 18 h with an intensifying screen and processed for autoradiography Figure 1 Eect of Met-DNA fragments on osteopontin promoter activity. Rama 37 cells were transiently cotransfected with the full length C9-Met-DNA, reversed C9-Met-DNA (Rev. C9-Met-DNA) or fragments of C9-Met-DNA (pM1 etc), and with the CAT reporter gene coupled downstream of the OPN promoter, all in their respective vectors. The mean +s.d. of the CAT activity of the promoter-reporter construct with various additions relative to the promoter-reporter construct alone for three separate experiments is shown for the optimum (optim) input of vector cloned DNA fragments (ng). *Signi®cantly dierent from 1.0 (Student's t-test, P50.03). {Signi®cantly dierent from 4.2 (Student's t-test, P50.05). Rama 37 cell line (Dunnington et al., 1983) was cultured in Dulbecco's modi®ed Eagle's medium, 10% (v/v) fetal calf serum, 100 mg/ml penicillin, 100 mg/ml streptomycin (all GIBCO ± BRL, Glasgow, UK), harvested and seeded in multiwell plates at 2.5610 5 cells/3.5 cm well in 1 ml serum-free medium. After 24 h, cells were cotransfected with the predetermined optimum amount of DNA fragments, 200 ng b-galactosidase control expression plasmid and 650 ng promoter-reporter plasmid (El-Tanani and Green, 1997). Cells were incubated for 48 h and then were harvested in 300 ml Reporter Lysis Buer (Promega), and CAT and control b-galactosidase activities were assayed on 100 and 150 ml aliquots, respectively (El-Tanani and Green, 1997). CAT activity was normalized relative to bgalactosidase activity and maximum activity was reached by 48 h, results at 72 h were similar. The C9-Met-DNA (Rudland and Barraclough, 1997) and in the reverse orientation were obtained by digestion of the relevant recombinant pBluescript vector (Chen et al., 1997b) using XbaI and SalI or EcoRI and XbaI restriction enzymes, respectively, and cloned into PSI vector (Promega, Madison). C9-Met-DNA was cut further with suitable restriction enzymes to yield pM1 to pM8 and subcloned into pBK-CMV vector (Stratagene, LaJolla, CA, USA). pM9 was obtained by ampli®cation of C9-Met-DNA with Taq PCR using forward primer TTA GAG TGC CGT CCT GAG and reverse primer ATG AGA GTT AGC CTT GAA, cloned into PCR 2.1 vector (Invitrogen, Carlsbad, CA, USA), then digested by EcoRI and subcloned into pBK-CMV vector. The synthetic oligonucleotides pM10, 11, 12 and the CAAAG-deleted pM12/D correspond to the following sequences: ATG AGC TCA TTG GAA AGG GGA GAA CCA GGC AAA GGT GTT GGC TGT GAC; CTC AGA ATT CTG AGG GGC AAA GGT TCA AGG CTA ACT CTC ATT ATA GAG; AAC CAG GCA AAG GTG TTG GC; AAC CAG GGT GTT GGC. They were cloned into the EcoRI sites of the pKB-CMV as above. The 2.3 kbp fragment of the 6 kbp osteopontin promoter from Dr A Ridall, University of Texas, Dental Branch, Houston, Texas (Ridall et al., 1995) , was ampli®ed with Taq PCR using AAG CCT GGA TGT CCT TCT CTG CTT and GTC GAC ACT GCA AAG CCA AGG ATG as forward and reverse primers, respectively, cloned into PCR 2.1 vector (Invitrogen), released by digestion with HindIII and SalI and then coupled to a CAT reporter construct to measure its activity (El-Tanani and Green, 1997). The ampli®ed product was freed of any mutations reduced upon their prior incubation with whole-cell and nuclear extracts from Rama 37 cells, but the fragments lacking the CAAAG-Tcf recognition sequences were unaected (Figure 2 ). The electrophoretogram for pM9-DNA contained several retarded bands consistent with several Tcf-binding sites, whilst that for pM12-DNA contained a single retarded band consistent with one Tcf-binding site. The original 20 bp pM12-DNA and pM12-DNA with the GG sequence preceding the CAAAG substituted by AA yielded single retarded bands of the same mobility when incubated with Tcf-4 containing lysates (not shown). The proteins bound to pM9-and pM12-DNAs were identi®ed by subjecting the excised gel-region containing the retarded radioactive DNA bands to SDSpolyacrylamide gel electrophoresis. The 43 kDa protein was identi®ed as b-actin by sequence determination (not shown), Western blotting identi®ed the 34 kDa protein as Tcf-4, the 85 kDa protein as b-catenin and the 95 kDa protein as E-cadherin (Figure 3a,b,c) . These proteins represented the major bands in the stained gels and were present in whole-cell and nuclear extracts, except E-cadherin and actin which were present only in whole-cell extracts. They were absent from parallel regions of gel shifts using the Tcf sitedeleted pM12/D-DNA. When 32 P-labelled pM9-DNA or pM12-DNA were incubated with nuclear protein from Rama 37 cells and monoclonal antibody (MAb) to Tcf-4, but not Tcf-1, the mobilities of the retarded bands were reduced even further (not shown). No immunoreactive bands were observed with an antibody to Tcf-1 (not shown).
When a Tcf-4 expressing vector was cotransfected transiently into Rama 37 cells with pM9-or pM12-DNA and the OPN promoter-CAT reporter construct, about 90% of the stimulatory activity was suppressed. In contrast the expression of the closely-related Tcf-1 stimulated this promoter by a further 2.8-fold with either of these DNAs (Figure 4a) . If the Met-DNA fragments were omitted, the activity due to the OPN promoter alone was 90% inhibited by Tcf-4 and stimulated nearly threefold by Tcf-1 expressing vectors (not shown). When Rama 37 cells permanently transfected with C9-Met-DNA were tested for OPN promoter activity, they were 4.5-fold more active than the untransfected Rama 37 cells. This increased promoter activity was also suppressed to that of the Rama 37 levels by transient transfection with the Tcf-4 and stimulated with the Tcf-1 expression vector ( Figure  4a ).
Transient transfection of Rama 37 cells with DNA fragments active in stimulating the OPN promoter also speci®cally suppressed the levels of Tcf-4 mRNA ( Figure 4b ) and protein (Figure 4c) , reaching a minimum after 24 h and thereafter remaining relatively constant up to 48 h. In contrast, there was virtually no change in the unrelated c-fos and actin mRNAs ( Figure  4b ) and no Tcf-1 mRNA/protein was detected (not shown). Endogenous mRNA levels for OPN were also increased in these pM9-and pM12-DNA transiently transfected systems, starting at about 48 h and reaching a maximum of 3.5-fold after 72 h (Figure 4d ). The permanently C9-Met-DNA-transfected Rama 37 cells also possessed lower levels of Tcf-4 mRNA and protein than their untransfected parents, whereas the mRNA levels of c-fos and actin remained unchanged ( Figure   Figure 3 Identi®cation of proteins bound to Met-DNA fragments. (a,b) Nuclear or (c) whole-cell extracts from Rama 37 cells (lane 1) and proteins eluted from the retarded radioactive bands (Figure 2 ) of pM9-DNA (lane 2) and pM12-DNA (lane 3) (a,b only) were separated by polyacrylamide gel electrophoresis and subjected to Western blotting using antibodies to (a) Tcf-4, (b) bcatenin and (c) E-cadherin. Molecular weights of standard proteins are shown and arrows point to positions of authentic proteins. Western blots were performed with 10 mg cell nuclear extract (El-Tanani and Green, 1997) or its equivalent from the DNA gels of Figure 2 obtained by cutting out the relevant areas and electrophoresed through 10% (w/v) polyacrylamide, 1% (w/ v) SDS gels. The proteins were then transferred by blotting onto an Immobilon P membrane (Millipore Corporation, Watford, UK) (Oates et al., 1996) . The membranes were incubated with blocking buer containing 5% (w/v) Marvel, 0.02 M Tris-HC1 (pH 7.0), 0.9% (w/v) NaC1, 0.1% (v/v) Tween 20, then with 1 : 500 MAb to Tcf-4 (11) or 1 : 500 rabbit polyclonal antibodies to b-catenin or E-cadherin. Bound antibodies were located by a further incubation with 1 : 5000 horseradish peroxidase-conjugated rabbit anti-mouse (for anti-Tcf-4) or swine anti-rabbit IgGs, visualised with Super Signal West Pico Chemiluminescence System (Pierce and Wariner, Chester, UK) and exposed to Kodak Scienti®c Imaging ®lm (Anachem, Luton, UK). Prior incubation of primary antibodies with their corresponding antigens abolished bands observed in these Western blots. Mouse MAbs to Tcf-1 and Tcf-4 were the gifts of Prof H Clevers (Schilham and Clevers, 1998) , rabbit antibodies to b-catenin and E-cadherin were purchased from Santa Cruz (CA, USA) 4b,c). Moreover, the Rama 37 cells permanently transfected with C9-Met-DNA also possessed 4.4-fold more OPN mRNA than the untransfected Rama 37 cells (Figure 4d ).
Three lines of evidence have been presented to show that the active sequence of the C9-Met-DNA for stimulating OPN mRNA transcription is a recognition site for the Tcf family of transcription factors: OPN promoter stimulation, Tcf-4 binding in vitro and Tcf-4 inhibition in vivo. These results are not unique to the rat mammary cell lines employed, since identical results have been obtained in human HeLa cells and in monkey COS-1 cells (not shown). Since there are three CAAAG sequences in the rat OPN promoter used here (Ridall et al., 1995) and addition of active C9-Met-DNA fragments speci®cally sequester Tcf-4 and related proteins, this transcription factor presumably acts to suppress OPN promoter activity. Although the three CAAAG sequences in the rat OPN promoter are preceded by the dinucleotides A/T, A/T as anticipated (van de Wetering et al., 1991) rather than GG in both instances in C9-Met-DNA, the AA or GG-containing pM12-DNAs both competed for binding to reticulocyte lysates containing Tcf-4 in the same concentration range (unpublished results). Presumably the transfected CAAAG-containing DNAs can then sequester Tcf-4 in the Rama 37 cells and thereby stimulate the activity of the transiently transfected OPN promoter-reporter construct. The reason for the contrasting eects of Tcf-4 and Tcf-1 in either inhibiting or enhancing the OPN promoterreporter activity is unknown, but only Tcf-4 mRNA and protein are detectable in the Rama 37 cell system, and hence can have a regulatory role in vivo. The levels of total Tcf-4 mRNA, in addition to nuclear Tcf-4 protein, are also speci®cally reduced in the same time period by CAAAG-containing transfected DNAs, albeit to a more limited extent, suggesting that the transfected DNAs also somehow cause a reduction in the level of Tcf-4 mRNA, as well as sequestering the remaining Tcf-4 protein.
There are ®ve other Met-DNAs termed C2, C5, C6, C12 and C20-Met-DNA in addition to the C9-Met-DNA, and all possess potential Tcf-CAAAG recognition sequences (Chen et al., 1997b) . The one other transcription factor recognition sequence common to all six Met-DNAs and the 14 other potential transcription factor recognition sequences present in C9-Met-DNA (Rudland and Barraclough, 1997) all occur in DNA fragments which fail to stimulate the activity of the OPN promoter-reporter construct. It is therefore probable that all six Met-DNAs stimulate Transient transfections were conducted as described in Figure 1 . Tcf-4 and Tcf-1 cDNAs were obtained from Prof H Clevers, University Hospital, Utrecht, Holland (Schilham and Clevers, 1998 ) and were separately cloned in the pBK-CMV expression vector as above. Northern blots for mRNAs were performed on total RNA isolated from the relevant cells by TRIzol reagent (GIBCO ± BRL). They were hybridised separately in turn to 32 Plabelled cDNAs for Tcf-4, a-actin, c-fos, OPN and subjected to autoradiography for 48 h using Fuji X-Omat ®lm and an intensifying screen (El-Tanani and Green, 1997) . The cDNAs were radioactively labelled by random primed synthesis to a speci®c activity of 5610 8 d.p.m./mg. The cDNAs for smooth muscle a-actin, c-fos and OPN were obtained as described previously (Oates et al., 1996) . Western blots with cell nuclear extracts isolated from transiently transfected Rama 37 cells or from C9-Met-DNA permanently transfected Rama 37 cells (Chen et al., 1997b) were performed as described in Figure 3 transcription of the OPN gene by a common mechanism. Moreover, although all six Met-DNAs have been isolated from a single human breast cancer cell line, DNA from cell lines isolated from breast metastases in rats and in humans contain fragments with similar metastasis-inducing properties (Davies et al., 1994) . In pilot studies, sequences within C9-Met-DNA have also been shown to occur preferentially in genomic DNA from about half of the breast carcinomas examined, but not in genomic DNA from normal tissue, when analysed by Southern blotting techniques (Chen et al., 1997b) . Moreover, other studies have shown that elevated levels of OPN are correlated with early patient death from metastatic disease in human breast (Tuck et al., 1998) and gastric cancers (Ue et al., 1998) . Thus, the mechanism by which such human DNA sequences induce dissemination and metastasis in model rodent systems may have some applicability to the corresponding human diseases.
Tcf-4 is a member of the high mobility group architectural transcription factors which control developmental events in diverse species (Schilham and Clevers, 1998) . Recently Tcf gene products have been found to constitute a downstream component of the Wingless/Wnt signal transduction pathway (Cavallo et al., 1998) . Tcf-related factors introduce sharp bends in the DNA and facilitate interactions with other transcription factors by helping to assemble a large nucleoprotein complex (Love et al., 1995) which can trigger both positive and negative regulatory signals (Schilham and Clevers, 1998) . Tcf-4 has been shown previously to be expressed in mammary epithelium (Barker et al., 1999) , but nothing is known about the role of the Tcf family in breast cancer. However, the Tcf signalling pathway has been implicated in the generation of some colon cancers. For example mutations in the APC gene enable b-catenin to be released from its normal complex with APC in the membrane/cytoskeleton, where it also binds to Ecadherin (Hugh et al., 1999) , and to form a complex instead with Tcf-4 in the nucleus Korinek et al., 1997) . One of the genes then upregulated by b-catenin, probably by targeting Tcfmediated repression is the protease, matrilysin (Crawford et al., 1999) . Now we have shown in a model system derived from the breast that one Met-DNA sequesters the Tcf-4 transcription factor in vitro together with its associated proteins b-catenin and Ecadherin, and is associated with downregulated Tcf-4 in vivo. In this way it permits activation of the promoter for the direct eector of tumour progression and metastasis in this system, osteopontin. It is suggested that this Tcf-4-mediated regulation of OPN gene expression may provide a novel mechanism for tumour progression and metastasis.
